Tag
MAY & BAKER NIGERIA PLC
Nigeria’s Biovaccines Nigeria Limited (BVNL) is set to begin production of vaccines before second quarter of 2023
MAY & BAKER NIGERIA PLC released its unaudited financial results for the third quarter of the year ended 30th...
In this article, we bring you some of Nigeria’s leading penny stocks outperforming the country’s inflation rate of 18.12%.
May & Baker Nigeria Plc has announced the signing of a manufacturing agreement with Sanofi Nigeria Limited.
May & Baker Nigeria Plc has announced the exit of its Director and Chairman of Board of Directors, Theophilus Danjuma.
@nsenigeria ended Tuesday’s trading session in negative territory. The All Share Index closed at 27,527.40 basis points, down 0.51%. Year to date, the index is down by 12.42%.
Shareholders of @maybakernigeria have approved a dividend payment of N345.04 million for the financial year ended 31st December 2018.
Following the divestment of its foods business which, on average, accounts for 23.36% of its revenue, May & Baker Nigeria Plc recorded a dip of 14.22% in topline from its continued operations, with turnover settling at NGN1.87bn.
May & Baker Nigeria Plc have just recently disclosed its financial statement for Q1 period ended March 31st. Below are the key highlights of the results:
The Management and Board of May & Baker Plc, today, announced dividend payment of 20 kobo per 50 kobo share.
Dr Onyisi has also been recommended by May & Baker's board for election as a Director in the company.
May & Baker Nigeria Plc has earned N1.86 billion from Rights Issue after the Nigeria Stock Exchange (NSE) listed additional 745,234,886 ordinary shares of the drug manufacturing company.